Abstract
You will learn how to automatically create custom and optimized media formulations based on peer-reviewed research for induced pluripotent stem cell (iPSC)-based therapyIndependent of the cell type used in your process, learn how you can improve key critical quality attributes related to your therapy by having a customized media formulationLearn how to maintain IP ownership of the formulations you create and easily order them in the preferred format, size, and packaging to reduce cost and mitigate supply chain risksInstantly canvas publicly accessible scientific content and extract component and concentration level information to dramatically reduce the time to research and design custom formulationsDr Asma Ayari is Nucleus Biologics' Head of R&D, running Formulation Services & Product Development and has extensive experience in media analysis, testing and formulation for Cell and Gene Therapy. Asma did her PhD work in virology and immunology and brings a deep understanding of how complex cellular systems are affected by small changes in the chemical composition of the microenvironment. Dr Ayari holds a MSc. in Microbiology from University of Tunis and a PhD in Virology, Immunology and Metabolism from University of Lille in France.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
